TiGenix to acquire UK medical technology company for €16 million

Monday 16 November 2009

TiGenix NV of Belgium is set to acquire Orthomimetics, a privately-held UK medical technology company, for shares valued at €16 million in order to extend its regenerative medicines franchise. 

 

 

 

 

 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium